Stock listing

ALKB Stock Price, News, Filings & Events — Alk-abello A/s Class B

Selected listing: ALKB · VIE · EUR · AT

This page tracks Alk-abello A/s Class B's ALKB:VIE listing on VIE in EUR for AT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALKB:VIE. ALKB:VIE is the stock-level entry point for investors researching Alk-abello A/s Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alk-abello A/s Class B is a publicly traded company in Denmark, listed under the ticker ALK B. The company has a market capitalization of approximately 8.25 billion USD. Alk-abello specializes in allergy immunotherapy products and solutions, contributing to advancements in allergy treatment and management.

ALKB:VIEEURATUpdated August 28, 2026
Alk-abello A/s Class B logo
Ticker
ALKB:VIE
Asset type
Stock
Market cap
$7.35B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
VIE
Currency
EUR

Alk-abello A/s Class B ALKB:VIE stock context

This page tracks Alk-abello A/s Class B's ALKB:VIE listing on VIE in EUR for AT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALKB:VIE. ALKB:VIE is the stock-level entry point for investors researching Alk-abello A/s Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alk-abello A/s Class B is a publicly traded company in Denmark, listed under the ticker ALK B. The company has a market capitalization of approximately 8.25 billion USD. Alk-abello specializes in allergy immunotherapy products and solutions, contributing to advancements in allergy treatment and management.

Latest news from Alk-abello A/s Class B

All Alk-abello A/s Class B news →

Alk-abello A/s Class B earnings calls

Research Alk-abello A/s Class B

Alternate listings